TrialCurrent HIV research2017

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial.

Joel Gallant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.